发布求助
文献互助 智能选刊 最新文献

Clinical Lymphoma, Myeloma & Leukemia最新文献

筛选
英文 中文
In Situ Visualisation of BCMA Bispecific Antibody and the Myeloma Immune Microenvironment BCMA双特异性抗体与骨髓瘤免疫微环境的原位可视化
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03433-0
Jeremy Er, Raymond Yip, Joel Rimes, Amanda Light, Ellen Tsui, Mark Dowling, Yunshun Chen, Simon Harrison, Edwin Hawkins
{"title":"In Situ Visualisation of BCMA Bispecific Antibody and the Myeloma Immune Microenvironment","authors":"Jeremy Er, Raymond Yip, Joel Rimes, Amanda Light, Ellen Tsui, Mark Dowling, Yunshun Chen, Simon Harrison, Edwin Hawkins","doi":"10.1016/S2152-2650(25)03433-0","DOIUrl":"10.1016/S2152-2650(25)03433-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S20"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MZB1-Directed HLA-Dependent CAR T Cells for Targeting B-Cell Malignancies 靶向b细胞恶性肿瘤的mzb1靶向hla依赖性CAR - T细胞
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03414-7
Elena Maroto Martin, Marina He, Yingjie Zhao, Jessica Encinas, Sara Mangesh Kolhatkar, Roberto García-Vicente, María Linares, Mubin Tarannum, Zachary R. Hunter, Steven P. Treon, Rizwan Romee, Mehmet Samur, Mariateresa Fulciniti, Jianzhu Chen, Nikhil Munshi
{"title":"MZB1-Directed HLA-Dependent CAR T Cells for Targeting B-Cell Malignancies","authors":"Elena Maroto Martin, Marina He, Yingjie Zhao, Jessica Encinas, Sara Mangesh Kolhatkar, Roberto García-Vicente, María Linares, Mubin Tarannum, Zachary R. Hunter, Steven P. Treon, Rizwan Romee, Mehmet Samur, Mariateresa Fulciniti, Jianzhu Chen, Nikhil Munshi","doi":"10.1016/S2152-2650(25)03414-7","DOIUrl":"10.1016/S2152-2650(25)03414-7","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S7-S8"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clonal Hematopoiesis of Indeterminate Potential (CHIP) Does not Impact the Efficacy of BCMA-Directed Chimeric Antigen Receptor (CAR)-T Cells in Patients with Relapsed/Refractory Multiple Myeloma 不确定电位克隆造血（CHIP）不会影响bcma定向嵌合抗原受体(CAR)-T细胞治疗复发/难治性多发性骨髓瘤患者的疗效
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03479-2
Sophie Carlson, Benjamin Puliafito, Paige Brown, Kosuke Kawai, T. Niroshi Senaratne, Thomas D. Lee, Tasha Lin, John M. Timmerman, Sarah Larson
{"title":"Clonal Hematopoiesis of Indeterminate Potential (CHIP) Does not Impact the Efficacy of BCMA-Directed Chimeric Antigen Receptor (CAR)-T Cells in Patients with Relapsed/Refractory Multiple Myeloma","authors":"Sophie Carlson, Benjamin Puliafito, Paige Brown, Kosuke Kawai, T. Niroshi Senaratne, Thomas D. Lee, Tasha Lin, John M. Timmerman, Sarah Larson","doi":"10.1016/S2152-2650(25)03479-2","DOIUrl":"10.1016/S2152-2650(25)03479-2","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S50-S51"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Effectiveness of Teclistamab vs Real-World Physician’s Choice of Carfilzomib-and/or Pomalidomide-Based Regimens in LocoMMotion and MoMMent in TCE RRMM Teclistamab与现实世界医生选择卡非佐米和/或波马度胺为基础的方案在TCE RRMM的运动和运动中的比较效果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03473-1
María-Victoria Mateos, Katja Weisel, Francesca Ghilotti, Joris Diels, Tassia Decimoni, Pamella Villanova, Anielle Jacomini, Simone Forny, Monserrat Rojas, Mary Slavcev, Marguerite O’Hara, Philippe Moreau
{"title":"Comparative Effectiveness of Teclistamab vs Real-World Physician’s Choice of Carfilzomib-and/or Pomalidomide-Based Regimens in LocoMMotion and MoMMent in TCE RRMM","authors":"María-Victoria Mateos, Katja Weisel, Francesca Ghilotti, Joris Diels, Tassia Decimoni, Pamella Villanova, Anielle Jacomini, Simone Forny, Monserrat Rojas, Mary Slavcev, Marguerite O’Hara, Philippe Moreau","doi":"10.1016/S2152-2650(25)03473-1","DOIUrl":"10.1016/S2152-2650(25)03473-1","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S47"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Talquetamab Dosing Strategies in the United States: Real-world Insights From Over 250 Patients Talquetamab在美国的给药策略：来自250多名患者的真实世界见解
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03474-3
Rahul Banerjee, Ruibin Wang, Yi-Hsuan Liu, Jinghua He, Saurabh Patel, Xinke Zhang
{"title":"Talquetamab Dosing Strategies in the United States: Real-world Insights From Over 250 Patients","authors":"Rahul Banerjee, Ruibin Wang, Yi-Hsuan Liu, Jinghua He, Saurabh Patel, Xinke Zhang","doi":"10.1016/S2152-2650(25)03474-3","DOIUrl":"10.1016/S2152-2650(25)03474-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S47-S48"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering Myeloid Cell Dynamics within the Osteolytic Lesion Tumor Microenvironment to Overcome Immunosuppression in Multiple Myeloma 在骨化病变肿瘤微环境中破译髓细胞动力学以克服多发性骨髓瘤的免疫抑制
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03466-4
Joshua Rivera, Qi Yan, Saeed Daneshmandi, Romain Lannes, Kenneth Anderson, Nikhil Munshi, Jens Hillenglass, Philip McCarthy, Hemn Mohammadpour, Mehmet Samur
{"title":"Deciphering Myeloid Cell Dynamics within the Osteolytic Lesion Tumor Microenvironment to Overcome Immunosuppression in Multiple Myeloma","authors":"Joshua Rivera, Qi Yan, Saeed Daneshmandi, Romain Lannes, Kenneth Anderson, Nikhil Munshi, Jens Hillenglass, Philip McCarthy, Hemn Mohammadpour, Mehmet Samur","doi":"10.1016/S2152-2650(25)03466-4","DOIUrl":"10.1016/S2152-2650(25)03466-4","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S42"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belantamab for the Treatment of Multiple Myeloma: Results from Part 1 of the First-in-Human Phase 1/2 DREAMM-20 Trial Belantamab用于治疗多发性骨髓瘤：来自首次人体1/2期dream -20试验的第一部分结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03460-3
Hang Quach, Bradley Augustson, Linda Barton, Edvan Crusoe, Jeffrey Shang-Yi Huang, Vania Hungria, Marek Hus, Karthik Ramasamy, Teruhito Takakuwa, Dok Hyun Yoon, Rupam Pal, Shreyan Banerjee, Hari Narayan, Wei Sun, Malika Ahras, Seema Shafi-Harji, Sarantos Kaptanis, Giulia Fulci, Brandon E. Kremer, Chang-Ki Min
{"title":"Belantamab for the Treatment of Multiple Myeloma: Results from Part 1 of the First-in-Human Phase 1/2 DREAMM-20 Trial","authors":"Hang Quach, Bradley Augustson, Linda Barton, Edvan Crusoe, Jeffrey Shang-Yi Huang, Vania Hungria, Marek Hus, Karthik Ramasamy, Teruhito Takakuwa, Dok Hyun Yoon, Rupam Pal, Shreyan Banerjee, Hari Narayan, Wei Sun, Malika Ahras, Seema Shafi-Harji, Sarantos Kaptanis, Giulia Fulci, Brandon E. Kremer, Chang-Ki Min","doi":"10.1016/S2152-2650(25)03460-3","DOIUrl":"10.1016/S2152-2650(25)03460-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S38"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145099102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell-Free BCL2 exRNA, but not MYC or MIZ1, Identifies Smouldering Myeloma with a High Risk of Progression among Patients in the Myeloma Related Disease Registry (MRDR) 无细胞BCL2 exRNA，而非MYC或MIZ1，在骨髓瘤相关疾病登记处（MRDR）的患者中识别具有高风险进展的阴燃骨髓瘤
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03449-4
Daniel Wong, Tiffany Khong, Sridurga Mithraprabhu, Andrew Spencer, Jessie Zhao, Nicholas Bingham, Malarmathy Ramachandran
{"title":"Cell-Free BCL2 exRNA, but not MYC or MIZ1, Identifies Smouldering Myeloma with a High Risk of Progression among Patients in the Myeloma Related Disease Registry (MRDR)","authors":"Daniel Wong, Tiffany Khong, Sridurga Mithraprabhu, Andrew Spencer, Jessie Zhao, Nicholas Bingham, Malarmathy Ramachandran","doi":"10.1016/S2152-2650(25)03449-4","DOIUrl":"10.1016/S2152-2650(25)03449-4","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S30"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elranatamab in Combination With Daratumumab and Lenalidomide (EDR) in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Not Eligible for Transplant: Initial Results from MagnetisMM-6 Part 1 Elranatamab联合Daratumumab和来那度胺（EDR）治疗新诊断的不适合移植的多发性骨髓瘤（NDMM）患者：来自MagnetisMM-6 Part 1的初步结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03411-1
Suzanne Trudel, Hang Quach, Ludek Pour, Sebastian Grosicki, Hanlon Sia, Jiří Minařík, Ja Min Byun, Cyrille Touzeau, Carmine Liberatore, Sharon T. Sullivan, Eric Leip, Eeman Shaikh, Andrea Viqueira, Meletios Dimopoulos
{"title":"Elranatamab in Combination With Daratumumab and Lenalidomide (EDR) in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Not Eligible for Transplant: Initial Results from MagnetisMM-6 Part 1","authors":"Suzanne Trudel, Hang Quach, Ludek Pour, Sebastian Grosicki, Hanlon Sia, Jiří Minařík, Ja Min Byun, Cyrille Touzeau, Carmine Liberatore, Sharon T. Sullivan, Eric Leip, Eeman Shaikh, Andrea Viqueira, Meletios Dimopoulos","doi":"10.1016/S2152-2650(25)03411-1","DOIUrl":"10.1016/S2152-2650(25)03411-1","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S5"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Composition and Functional State of T and NK Cells in Extramedullary Myeloma Tumor Microenvironment 髓外骨髓瘤肿瘤微环境中T、NK细胞的组成及功能状态
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03431-7
Anjana Anilkumar Sithara, Veronika Kapustova, David Zihala, Ondrej Venglar, Daniel Bilek, Moutaz Helal, Mara John, Eva Radova, Lucie Broskevicova, Jan Vrana, Gabriela Havlova, Ludmila Muronova, Serafim Nenarokov, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Sandra Charvatova, Martin Havel, Michal Simicek, Angela Riedel, Tomas Jelinek
{"title":"Composition and Functional State of T and NK Cells in Extramedullary Myeloma Tumor Microenvironment","authors":"Anjana Anilkumar Sithara, Veronika Kapustova, David Zihala, Ondrej Venglar, Daniel Bilek, Moutaz Helal, Mara John, Eva Radova, Lucie Broskevicova, Jan Vrana, Gabriela Havlova, Ludmila Muronova, Serafim Nenarokov, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Sandra Charvatova, Martin Havel, Michal Simicek, Angela Riedel, Tomas Jelinek","doi":"10.1016/S2152-2650(25)03431-7","DOIUrl":"10.1016/S2152-2650(25)03431-7","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S18-S19"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信